InvestorsHub Logo
Followers 4
Posts 524
Boards Moderated 0
Alias Born 04/22/2015

Re: None

Monday, 02/01/2016 8:09:25 PM

Monday, February 01, 2016 8:09:25 PM

Post# of 190
Bleeding has dried up. Suspecting news with secondary pricing soon. Depends on the evaluation of the dilution. NEO$ might get $15 a share again.

But I suspect those underwriter would probably negotiate the price down to $10-$13. But once the new drug is in manufacture pipeline it could go up to $30 pps. I shorted the momentum and got back in today before close at $10.80. Only 1k. Let's see how this plays.